Related Experiment Video
Updated: Jun 17, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumor progression
Amparo Cano1, Francisco Portillo
1Departmento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain. acano@iib.uam.es
Abstract:
EMT is a complex process whereby cells lose cell-cell interactions and other epithelial properties whilst acquiring a migratory and mesenchymal phenotype. EMT is presently recognized as an important even for tumor invasion and metastasis. Functional E-cadherin loss is a hallmark of EMT and required for tumor invasion in the majority of carcinomas. Transcriptional downregulation is one of the major mechanisms for E-cadherin suppression in carcinomas. In the last decade several E-cadherin repressors, belonging to different transcriptional families, have been identified that, importantly, also act as potent EMT inducers. One of the last additions to EMT regulators are the class I bHLH factors E2-2 (also known as TCF4). However, the hierarchical and functional interrelations between the different EMT inducers are still poorly understood. Here, we comment on the new and so far unrecognized function of E2-2 factors in EMT and discuss on the potential interactions among various EMT inducers. Emerging evidence supporting the participation of TCF4 in human malignancies is also discussed. Thus, increasing understanding of EMT and its regulators is providing meaningful insights into the present knowledge on tumor progression.
Insights
Epithelial-mesenchymal transition (EMT) drives tumor invasion. New research highlights the role of E2-2 (TCF4) as a key regulator in this process, impacting cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for tumor invasion and metastasis.
- Loss of E-cadherin is a key event in EMT, often due to transcriptional downregulation.
- Several EMT inducers have been identified, but their interrelations are not fully understood.
Purpose of the Study:
- To elucidate the role of class I basic helix-loop-helix (bHLH) factors, specifically E2-2 (TCF4), in EMT.
- To explore the hierarchical and functional interactions among different EMT inducers.
- To discuss the involvement of TCF4 in human malignancies.
Main Methods:
- Review and commentary on existing literature regarding EMT regulators.
- Analysis of emerging evidence on TCF4 function in EMT and cancer.
Main Results:
- E2-2 (TCF4) is identified as a significant regulator of EMT.
- Potential interactions between TCF4 and other EMT inducers are highlighted.
- Evidence suggests TCF4's participation in human malignancies.
Conclusions:
- Understanding E2-2 (TCF4) and its interactions with other EMT regulators provides critical insights into tumor progression.
- Further research into EMT mechanisms can inform cancer treatment strategies.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulation of Angiogenesis and Blood Supply
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Negative Regulator Molecules

